ConductScience.org, home

Paper18655183

Quercetin suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha) through inhibiting protein synthesis.

Lee DH and 1 other. J Cell Biochem, 2008. Cited by 64 papers, by iCite.

Cite this record

ConductScience Library. Quercetin suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha) through inhibiting protein synthesis. Papers, record 18655183. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18655183

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Quercetin suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha) through inhibiting protein synthesis.
PubMed
Journal
J Cell Biochem
PubMed
Year
2008
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
64
iCite
Relative citation ratio, by iCite
1.69
iCite
Revised in PubMed
2026-03-07
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee DHDae-Hee
2Lee YJYong J

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HypoxiaMajor topic
Hypoxia-Inducible Factor 1, alpha SubunitMajor topic
Protein BiosynthesisMajor topic
QuercetinMajor topic
Cell Line, Tumor
Female
Humans
Male
Vascular Endothelial Growth Factor A

Source PubMed

Download CSV of topics

Grants5

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
CA96989NCI NIH HHSUnited StatesR01CA096989PubMed and NIHNIH RePORTER
R01 CA096989NCI NIH HHSUnited StatesR01CA096989PubMed and NIHNIH RePORTER
CA121395NCI NIH HHSUnited StatesR03CA121395PubMed and NIHNIH RePORTER
R01 CA095191NCI NIH HHSUnited StatesR01CA095191PubMed and NIHNIH RePORTER
CA95191NCI NIH HHSUnited StatesR01CA095191PubMed and NIHNIH RePORTER

Download CSV of grants

Cited by36

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.

PMIDTitleJournalYearIn PapersSource
42093837A 'three-axis synergy' immunotherapeutic strategy for malignant bone tumors based on natural bioactives and bioactive materials.Bioact Mater2026https://conductscience.org/library/papers/42093837PubMed
41687517Tribulus terrestris L. confers protection against hypoxia induced pulmonary hypertension via regulation of HIF/ NF-κB signalling pathway.J Ayurveda Integr Med2026https://conductscience.org/library/papers/41687517PubMed
41614951Natural Phytochemicals as Inhibitors of HIF-1α in Breast Cancer: Review of Preclinical Evidence and Future Prospects.Curr Issues Mol Biol2026https://conductscience.org/library/papers/41614951PubMed
41596149Molecular Insights into the Synergistic Anticancer and Oxidative Stress-Modulating Activity of Quercetin and Gemcitabine.Antioxidants (Basel)2026https://conductscience.org/library/papers/41596149PubMed
40124557Recent Update of Natural Compounds as HIF-1α Inhibitors in Colorectal Carcinoma.Drug Des Devel Ther2025https://conductscience.org/library/papers/40124557PubMed
38799423Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment.Front Immunol2024https://conductscience.org/library/papers/38799423PubMed
38791387Electro-Metabolic Coupling of Cumulus-Oocyte Complex.Int J Mol Sci2024https://conductscience.org/library/papers/38791387PubMed
38429605Improved therapy for clear cell renal cell carcinoma: beta-hydroxybutyrate and quercetin target hypoxia-induced angiogenesis and multidrug resistance.Mol Biol Rep2024https://conductscience.org/library/papers/38429605PubMed
37736110Network analysis and molecular docking studies of quercetin as a potential treatment for prostate cancer.In Silico Pharmacol2023https://conductscience.org/library/papers/37736110PubMed
37637163Icariin activates far upstream element binding protein 1 to regulate hypoxia-inducible factor-1α and hypoxia-inducible factor-2α signaling and benefits chondrocytes.PeerJ2023https://conductscience.org/library/papers/37637163PubMed
37285263Single-cell profiling reveals a potent role of quercetin in promoting hair regeneration.Protein Cell2023https://conductscience.org/library/papers/37285263PubMed
36532768Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review.Front Pharmacol2022https://conductscience.org/library/papers/36532768PubMed
35890106Phytochemicals as Regulators of Tumor Glycolysis and Hypoxia Signaling Pathways: Evidence from In Vitro Studies.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/35890106PubMed
35774834The Regulation of Hypoxia Inducible Factor (HIF)1α Expression by Quercetin: an In Silico Study.Acta Inform Med2022https://conductscience.org/library/papers/35774834PubMed
35307904Quercetin potential effects against SARS-CoV-2 infection and COVID-19-associated cancer progression by inhibiting mTOR and hypoxia-inducible factor-1α (HIF-1α).Phytother Res2022https://conductscience.org/library/papers/35307904PubMed
35158943Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper.Cancers (Basel)2022https://conductscience.org/library/papers/35158943PubMed
33918290The Hallmarks of Flavonoids in Cancer.Molecules2021https://conductscience.org/library/papers/33918290PubMed
33401572Flavonoids Targeting HIF-1: Implications on Cancer Metabolism.Cancers (Basel)2021https://conductscience.org/library/papers/33401572PubMed
33235435HIF-1α is a Potential Molecular Target for Herbal Medicine to Treat Diseases.Drug Des Devel Ther2020https://conductscience.org/library/papers/33235435PubMed
32273826Resveratrol protects mitochondrial quantity by activating SIRT1/PGC-1α expression during ovarian hypoxia.Reprod Med Biol2020https://conductscience.org/library/papers/32273826PubMed

See all 36 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HIF1A3091PubTator's text mininghttps://conductscience.org/library/genes/3091NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/18655183

GET https://conductscience.org/api/papers/v1/18655183/cited_by?page=2